$AEHR

Aehr Test Systems (AEHR) Q1 2027 Earnings Call Transcript

Aehr Test Systems (AEHR) reported Q1 2027 non-GAAP net income of $9.4M, up 163% sequentially. Revenue outlook raised to $150M, up 200% YoY. Bookings totaled $46.7M, with a backlog of $109.3M. Demand for AI, silicon photonics, and power semiconductor solutions is driving growth. Key customers include AI processor and accelerator suppliers.

Original reporting
Published Nov 3, 2026, 10:03 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 3, 2026, 10:16 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Aehr Test Systems (AEHR) Q1 2027 Earnings Call Transcript — source image
Decision brief

The 30-second read

$AEHRBullishMed
01

Why it matters

The earnings call disclosed a 163% sequential net‑income rise and a higher FY2027 revenue target, indicating accelerating demand in AI hardware testing.

02

Market read

Strong earnings and upgraded guidance may attract investors seeking exposure to AI hardware infrastructure.

03

What to watch

Potential supply‑chain constraints or slower adoption of wafer‑level burn‑in could temper growth.

Relevance 7/10Novelty 8/10Timing: post‑earnings release

Background

Aehr Test Systems provides wafer‑level and package‑level burn‑in solutions for AI processors and other advanced semiconductors.

Company-level read

Ticker impact

$AEHRBullishHigh confidence
Context

AEHR reported Q1 2027 non‑GAAP net income of $9.4M and raised FY2027 revenue guidance to $150M, up from $130‑150M range.

Expected impact

likely upward pressure as market prices in higher revenue outlook

Evidence & confidence

The company disclosed a material increase in revenue guidance and strong backlog, which is new information for investors.

Market effects

Signals continued growth in AI‑related semiconductor test equipment, supporting peers in the AI hardware supply chain.

Primarily U.S. semiconductor sector, limited broader market effect.

Reinforces demand trends for AI processors worldwide.

Counterpoint

If the raised guidance is already priced in, the stock may face disappointment on execution risk.

Key entities

  • Aehr Test Systems

    Provider of semiconductor test and burn‑in equipment.

Related articles

$AAPLMed

US Stock Futures Trade Mixed Premarket As AAPL Margin Concerns Weigh On Tech — PLTR, AMD, AEHR In Focus

US stock futures were mixed on Tuesday, with AAPL down 4.5% premarket due to margin concerns despite strong Q4 revenue. ORCL rose 0.4% after a $20B share sale plan. PLTR fell 5% despite beating earnings. NVDA gained 1.3%, MRVL up 2% on acquisition news, AMD up 2.4% ahead of earnings. AEHR surged 15.5% on record revenue and strong outlook. Midterm elections and earnings calendar also in focus.

$AEHRHighAI 8/10

Why Is AEHR Stock Surging 10% Overnight?

Aehr Test Systems (AEHR) reported Q1 revenue of $33 million, up 200% year-on-year, and raised its fiscal 2027 revenue outlook to $150 million. The company's strong bookings and backlog of $109.3 million boosted investor confidence, driving a 10% overnight stock surge.

$AAPLHighAI 8/10

Apple, Palantir, Marvell Technology, Oracle and Aehr Test Systems: Why These 5 Stocks Are on Investors' Radars Today

Apple (AAPL) closed down 1.83% at $338.32, reporting Q4 revenue of $114.48B, up 12% YoY, and EPS of $2.10. Palantir (PLTR) fell 3.13% to $178.34, with Q3 revenue up 96% YoY. Marvell (MRVL) plunged 12.72% to $171.41 after announcing a $115B acquisition. Oracle (ORCL) dropped 8.76% to $119.22. Aehr (AEHR) fell 6.23% to $51.47, reporting Q1 revenue up 200% YoY.

$AEHRMed

Aehr Test Revenue Triples to $33M as Its Backlog Rises 6.5x

Aehr Test Systems reported fiscal Q1 revenue of $33.0M, up 200% YoY, and raised its fiscal 2027 revenue outlook to $150M. The company's backlog rose to $109.3M, covering 93% of the remaining revenue needed to meet the new target. CEO Gayn Erickson attributed growth to AI demand, with orders from unnamed major customers. GAAP net income was $7.2M, or $0.21 per diluted share, up from a loss a year earlier. The company's book-to-bill ratio was approximately 1.4.